Tag: IMMU

PROW, RNN & Extended Watchlist

Record-Setting ‘Green Rush’ Begins to Subside
–
Like all good things, the frenzied buying of countless pot stocks largely came to an end during yesterday’s session. It was a historic week; an overwhelming trend caused by sheer excitement over Colorado’s precedent-setting entry into the post-prohibition era, and we were happy to cover every step, taking profits along the way! Granted, the main wave of hysteria is now over, but our continued interest in the sector as a whole will not wane. As we stated previously, this story has only just begun to be written. Even as many of the huge runners we’ve tracked began to pull back, others maintained their trends, and still others came down to find support only to rebound and provide bounce opportunities. Rest assured, we will remain hot on the trail of any possible chance at added profits within this sector that has been so good to us for so long a time. For now, it’s time to shift gears and talk about some of our other interests that were forced to the back burner in all the excitement.

Progress Watch Corp. PROW

PROW has brought us some really impressive gains in the short time that we’ve been including it in our reports. When we first began talking about it (12/20/13, trading at .0065) we were especially interested in its tight share structure. That day, we said that the 50DMA rising sharply toward the 200DMA “should lead to a golden cross in the weeks and months ahead.”  That golden cross is now in progress as the stock ran into the close yesterday, attaining four cents, an increase of 515% off of the bottom we observed just twelve trading sessions ago.

As the value of the stock increases, we’re going to be looking for support levels to hold at areas of previous resistance. In the event of any pullbacks, we would like to see support hold at .025, and below that, .013, in order to remain bullish on PROW.

Rexhan Pharmaceuticals, Inc. RNN

Back on December 11th, we tagged RNN for the first time in our extended watchlist, and were rewarded with an intraday run of 26% from .4026 to  .5179. Even as marijuana stocks were breaking out over the past couple of days, we were still tracking this stock’s impressive run via our extended watchlists, and yesterday, saw a high of .765. That marks an increase of 90% from our observed low, a figure which is being pushed even higher this morning; pre-market trades have gone off as high as .929, so things could get very interesting from here. This spike seems to have been catalyzed by a recent press announcement from RNN.


The following PR was released under the headline: “RX-3117 has Shown Efficacy Against Gemcitabine-Resistant Human Cancer Cell Lines and a Broad-Spectrum of Anti-Cancer Activity “

ROCKVILLE, Md., Jan 08, 2014 (BUSINESS WIRE) — Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN) a clinical stage biopharmaceutical company, announced today the initiation of a Phase Ib clinical trial to study the safety and efficacy of RX-3117 in cancer patients with solid tumors. RX-3117 is a next-generation cancer cell specific drug candidate that possesses a broad spectrum of anticancer activity with reduced side effects. In an exploratory Phase I clinical trial conducted in Europe, RX-3117 demonstrated oral bioavailability, and safety and tolerability in cancer patients with solid tumors. >> FULL PR

Extended Watchlist:
CNAT, BBRY, IMMU, BLDP, NSPH, RTRX

Happy New Year from Blue Horseshoe Stocks

With tomorrow’s holiday splitting another week right down the middle, we’d like to take this opportunity to wish our audience a very safe, healthy and Happy New Year. 2013 was an extremely successful year for us, and we are really excited to make 2014 even better!

At this point all of our regular readers are aware of our ongoing interest in marijuana -related stocks. We’ve covered this relatively new and rapidly growing industry tenaciously over the past year-and-a-half, and to our great pleasure, it has provided us with countless opportunities to profit.

Cannabis Science, Inc. CBIS

CBIS is an old favorite of ours that has delivered the goods on several occasions. Most recently, following our latest report which included the stock (12/19), CBIS touched its 52-wk low at .028, and has been really heating up since that time, reaching a high of .04 yesterday, good for a rebound of 43%

The stock closed at the high-of-day on more than 5.5x its 3mo. average volume, which certainly qualifies CBIS as a potential momentum play.

Here are some of the other stocks we’ve been  continuously tracking in the cannabis industry:

Hemp, Inc. HEMP,

Medical Marijuana, Inc. MJNA

Growlife, Inc. PHOT

Also consider: FITX, GRNH, SKTO, TRTC (Click here to view a past report containing much larger list of marijuana-related stocks)

We want to have the sector as a whole on watch as these plays are heating up, and seem poised to begin the New Year on a strong note. That fact, in concert with all of the recent progress that marijuana has made on both legislative and social levels, has us thinking that 2014 could be a landmark year for marijuana related stocks.

We also prepared a video chart presentation on the subject:

Progress Watch Corp. PROW

We first alerted on PROW back on Dec. 20th, at which time the stock saw a low of .0065, and we subsequently followed it to a high of .013. (+100%) After pulling back to .008 the following day, the stock has now surged back to re-test that .013 mark, giving us chances at up to an additional 65% gain.

PROW is likely to remain on our radar and in our reports well into the New Year.

Kandi Technologies Group, Inc. KNDI

KNDI came off of yesterday’s morning report to have a solid session, so we wanted to congratulate anyone who was able to take advantage. The stock saw a daily low of 11.50, followed by the high at 12.79, marking an intraday gain of just over 11%  A pretty good move for a stock in that price range, and a nice addition to the significant gains we’ve already seen from KNDI.

Extended Watchlist:
DROP, ONVO, CYTR, IMMU, LIVE, DRYS, FREE, GNK, MDNT(Readers pick, coming off recent 52week lows, thanks to John)

TSLA, PLUG, ETRM, OMED & Extended Watchlist

Tesla Motors, Inc. TSLA – Options
–
Back on November 29th, we were noticing that conditions on the TSLA chart had been exhibiting signs of a coming uptrend, and as a result, we presented a few options trading ideas that we felt had a reasonable chance of success. In particular, the 12/21 $120 Calls, and the 12/27 $130 Calls. We were rewarded for our interest, as the stock did indeed find its legs and begin to run following that report.

Since then we’ve seen some major moves out of those contracts, as the $120 Calls ended up trading from a low of 8.40, all the way up to yesterday’s closing price of 25.46, a monstrous 203% gain. The $130 Calls saw their low at 5.03, and ended up closing at 17.07. That was good for an even larger 239% rip.

Chartwise, it appears as if resistance is sitting at $145.65, $151, and the 50DMA of $159.45, and there is a gap on the chart to fill from $160-176, so a push past those key resistance points could lead to more pronounced increases. We would continue to take advantage of the added gains on these contracts, and in the event of a sustained uptrend, would have to consider rolling our strike price up to higher level that we believe would still be pushed into the money.

Plug Power, Inc. PLUG

PLUG has been an old favorite of ours from last March when we caught it on our scanners coming off its 52-wk lows (.1155) and we’ve mentioned it on multiple occasions since that time. We’ve followed this play all the way up to current levels, which as a result of recent favorable reports on the company’s finances, have reached all the way up to this morning’s pre-market high of 1.41. That represents an increase of 1121% off of lows following our initial alert.

We’ll be continuing to monitor PLUG closely, and will certainly want to take part in today’s conference call/webcast in which the CEO will address the reasoning behind his statement that the company is on pace for a “blowout quarter.”, as well as other issues.

LATHAM, N.Y., Dec 04, 2013 (GLOBE NEWSWIRE via COMTEX) — Plug Power Inc. (Nasdaq:PLUG), a leader in providing clean, reliable energy solutions, will today host a conference call and webcast during which CEO Andy Marsh will provide a business update for Plug Power and the Company’s expectations for the remainder of 2013 and for 2014.Since the October 8 business update call, the Company has seen an additional 17.8M USD in bookings. Plug Power is currently in negotiations with several large customers on sales agreements to deploy turn-key GenDrive solutions at multiple distribution centers. The Company believes this will significantly impact the fourth quarter bookings, as well as provide a recurring revenue stream from product, service and hydrogen contracts. Plug Power expects orders to range between 30M and 40M USD for the fourth quarter of 2013.

Plug Power has scheduled its conference call and webcast today at 10:30 am ET to review the Company’s business updates. Participants are encouraged to join the webcast to access the accompanying slide show presentation. The webcast can be accessed by going directly to the Plug Power Web site (www.plugpower.com) and selecting the webcast link on the home page. You can also call-in by dialing 877.407.8291. Andy Marsh will be joined by COO, Keith Schmid, and Vice President of Sales, Erik Hansen, to answer questions.

EnteroMedics, Inc. ETRM

ETRM was part of yesterday’s Extended Watchlist, and the stock went on to put up quite a performance. After touching a low of 1.48 shortly before 10:30am, ETRM would spend the rest of the day pressing upward to its high of day and closing price at 2.24. This marks an impressive intraday run of 51% on nearly 20x its 3mo. average volume.

We’ll certainly want to keep an eye on a stock with current momentum of this magnitude.

OncoMed Pharmaceuticals, Inc. OMED

Another winner from yesterday’s Extended Watchlist, OMED traded in a range from 22.10-31.99, which marks an intraday move of 45% Quite an impressive feat for a big-board stock in this price range.

Congrats to anyone who caught this, or any of the opportunities for significant profits afforded by the excellent calls in yesterday’s report.

Extended Watchlist:
IACH, BLDP, FCEL, CCXI, ABIO, IMMU, CPST, RAD, ICLD, CYTR,
HEM (Recently coming off 52week lows),
OCLS (FDA Approval news out this am)